1-17 of 17
Jacob S. Appelbaum
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

4q Copy Neutral Loss of Heterozygosity and KMT2A Partial Tandem Duplication Identified By Chromosomal Genomic Array Testing (CGAT) Correlated with Decreased Overall Survival in Acute Myeloid Leukemia (AML)

Suravi Raychaudhuri, Ted Gooley, Megan Othus, Xiaoyu Qu, Carole Shaw, Kathryn Russell, Rutu D. Vyas, Jacob S. Appelbaum, Anna B. Halpern, Roland B. Walter, Harry P. Erba, Min Fang, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2024) 144 (Supplement 1): 1530.
https://doi.org/10.1182/blood-2024-201213
Published: 2024
Journal Articles

Phase I Trial Combining Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) for Patients with Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms

Suravi Raychaudhuri, Ted Gooley, Allegra Rasmussen, Kim Quach, Zach Gill, Anna B. Halpern, Jacob S. Appelbaum, Cristina Maria Ghiuzeli, Paul C. Hendrie, Ryan D. Cassaday, Roland B. Walter, Elihu Estey, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2024) 144 (Supplement 1): 4288.
https://doi.org/10.1182/blood-2024-200883
Published: 2024
Journal Articles

Trials in Progress: Decoy-Resistant Interleukin-18 (DR-18) for Relapse or Pre-Emptive Treatment of Measurable Residual Disease after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial

Elizabeth Krakow, Laura Connelly-Smith, Catherine J. Lee, Dow Dunbar, Jeremy Barton, Beatrice P. McQueen, Geoffrey R. Hill, Jacob S. Appelbaum
Journal: Blood
Blood (2024) 144 (Supplement 1): 4780.1.
https://doi.org/10.1182/blood-2024-204129
Published: 2024
Journal Articles

Impact of Socioeconomic Factors on Access to and Outcomes of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Acute Myeloid Leukemia (AML): A Multi-Center Observational Study

Natalie Wuliji, Ted Gooley, Salene Jones, Aaron T. Gerds, Bruno Medeiros, Paul J. Shami, John Galvin, Kehinde Adekola, Selina Luger, Maria R. Baer, David A. Rizzieri, Tanya M. Wildes, Eunice S. Wang, Mikkael A. Sekeres, Sudipto Mukherjee, Julie C. Smith, Mitchell A. Garrison, Kiarash Kojouri, Jacob S. Appelbaum, Mary-Elizabeth M. Percival, Brenda M. Sandmaier, Frederick R. Appelbaum, Mohamed Sorror
Journal: Blood
Blood (2024) 144 (Supplement 1): 6.
https://doi.org/10.1182/blood-2024-202664
Published: 2024
Journal Articles

Loss of 5q Drives Evolution to Aneuploidy in an iPSC Model of Complex Karyotype AML

J. Philip Creamer, Suhita Ray, Sintra Stewart, Jacob S. Appelbaum, Min Fang, Elizabeth Swisher, Sergei Doulatov
Journal: Blood
Blood (2024) 144 (Supplement 1): 629.
https://doi.org/10.1182/blood-2024-206210
Published: 2024
Journal Articles

CLAG-M or FLAG-Ida Followed Immediately By Allogeneic Hematopoietic Cell Transplantation for Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm

Filippo Milano, Brenda M. Sandmaier, Mary-Elizabeth M. Percival, Sarah M Mahan, Laura C Roberts, Raya Mawad, Anna B. Halpern, Madi Brunette, Cristina Maria Ghiuzeli, Jacob S. Appelbaum, Naveed Ali, Roland B. Walter
Journal: Blood
Blood (2024) 144 (Supplement 1): 265.
https://doi.org/10.1182/blood-2024-209035
Published: 2024
Journal Articles

Shotgun Sequencing of Multi-Site Oral and Colonic Microbiota in Patients with AML: Site-Specific Patterns and Microbiota Decompartmentalization

Armin Rashidi, Suravi Raychaudhuri, Hakan Gem, Kristopher A Kerns, Jacob S. Appelbaum, Mary-Elizabeth M. Percival, Anna B. Halpern, Alexander Zevin, Samuel Minot, David R Dean, Roland B. Walter, Jeffrey S McLean
Journal: Blood
Blood (2023) 142 (Supplement 1): 2273.
https://doi.org/10.1182/blood-2023-185078
Published: 2023
Journal Articles

Prognostic Value of Copy Number Aberrations and Copy Neutral Loss of Heterozygosity in Acute Myeloid Leukemia

Suravi Raychaudhuri, Ted Gooley, Xiaoyu Qu, Carole Shaw, Kathryn Russell, Rutu D. Vyas, Jacob S. Appelbaum, Anna B. Halpern, Roland B. Walter, Min Fang, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2945.
https://doi.org/10.1182/blood-2023-184402
Published: 2023
Journal Articles

Phase I Trial Combining Venetoclax with G-CSF, Cladribine, Cytarabine, and Mitoxantrone (CLAG-M) for Patients with High-Grade Myeloid Neoplasms

Suravi Raychaudhuri, Ted Gooley, Zach Gill, Allegra Rasmussen, Anna B. Halpern, Jacob S. Appelbaum, Cristina Maria Ghiuzeli, Paul C. Hendrie, Ryan D Cassaday, Roland B. Walter, Elihu Estey, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2897.
https://doi.org/10.1182/blood-2023-181582
Published: 2023
Journal Articles

Evaluation of ECOG Performance Status at Diagnosis and Relapse in Patients with Acute Myeloid Leukemia

Michelle Y. Zhang, Carole Shaw, Kathryn Russell, Rutu D. Vyas, Anna B. Halpern, Jacob S. Appelbaum, Cristina Maria Ghiuzeli, Roland B. Walter, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2844.
https://doi.org/10.1182/blood-2023-174343
Published: 2023
Journal Articles

Treatment Outcomes for Adults with Mixed Phenotypic Acute Leukemia: A Large Single-Center Retrospective Study

Jennifer J. Huang, Jacob S. Appelbaum, Kathryn Russell, Carole Shaw, Ashley M. Eckel, Xueyan Chen, Rutu D. Vyas, Paul C. Hendrie, Anna B. Halpern, Raya Mawad, Ryan D Cassaday, Roland B. Walter, Mary-Elizabeth M. Percival, Cristina Maria Ghiuzeli
Journal: Blood
Blood (2023) 142 (Supplement 1): 2838.
https://doi.org/10.1182/blood-2023-188461
Published: 2023
Journal Articles

Time-Dependent Prediction of Relapse in Patients with Acute Myeloid Leukemia

John J. Lim, Megan Othus, Carole M. Shaw, Kathryn Russell, Anna B. Halpern, Jacob S. Appelbaum, Roland B. Walter, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2022) 140 (Supplement 1): 132–134.
https://doi.org/10.1182/blood-2022-169801
Published: 2022
Journal Articles

Addition of Sorafenib to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms Independent of FLT3-Mutation Status: Final Results of a Phase 1/2 Study

Anna B. Halpern, Eduardo P Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M. Percival, Ryan D. Cassaday, Vivian G. Oehler, Pamela S. Becker, Jacob S. Appelbaum, Janis L. Abkowitz, Johnnie J. Orozco, Sioban B. Keel, Paul C. Hendrie, Bart L. Scott, Cristina Ghiuzeli, Roland B. Walter, Elihu H. Estey
Journal: Blood
Blood (2022) 140 (Supplement 1): 8999–9001.
https://doi.org/10.1182/blood-2022-159882
Published: 2022
Journal Articles

Revised Prognostic Index for Patients with Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms in First Relapse

Noam E. Kopmar, Megan Othus, Olivia Gilbert, Kelda Schonhoff, Carole M. Shaw, Kathryn Russell, Anna B. Halpern, Jacob S. Appelbaum, Roland B. Walter, Paul C. Hendrie, Bart L. Scott, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2022) 140 (Supplement 1): 3199–3201.
https://doi.org/10.1182/blood-2022-166526
Published: 2022
Journal Articles

Time to Count Recovery after Post-Remission Chemotherapy in AML Patients

Gabrielle Paras, Megan Othus, Carole M. Shaw, Katie Russell, Anna B. Halpern, Jacob S. Appelbaum, Paul C. Hendrie, Roland B. Walter, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2022) 140 (Supplement 1): 6080–6081.
https://doi.org/10.1182/blood-2022-157586
Published: 2022
Journal Articles

A Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm

Colin D. Godwin, Megan Othus, Mary-Elizabeth M. Percival, Paul C. Hendrie, Bart L. Scott, Jacob S. Appelbaum, Anna B. Halpern, Vivian G. Oehler, Johnnie J. Orozco, Sioban B. Keel, Janis L. Abkowitz, Jason P. Cooper, Ryan D. Cassaday, Kaysey F. Orlowski, Anise J. Marshall, Clarisa N. Brown, Elihu H. Estey, Roland B. Walter
Journal: Blood
Blood (2021) 138 (Supplement 1): 34.
https://doi.org/10.1182/blood-2021-151658
Published: 2021
Journal Articles

Clinical Translation of SC-DARIC33: A Pharmacologically Controlled CD33-Targeted Anti-AML CAR T Cell Product Regulated By Low Nanomolar Concentrations of Rapamycin

Jacob S. Appelbaum, April Price, Joy Zhang, Kaori Oda, Sumati Sundaram, Paula Lewis, Sanela Bilic, Giacomo Tampella, Dong Xia, Anne-Rachel Krostag, Pauline So, Unja Martin, Wai-Hang Leung, Alexander Astrakhan, Mark Pogson, Jordan Jarjour, Josh Gustafson, Michael CV Jensen
Journal: Blood
Blood (2021) 138 (Supplement 1): 905.
https://doi.org/10.1182/blood-2021-154461
Published: 2021